Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108160 · ClinicalTrials.gov registry record · Phase 4
Preventing Staphylococcal (Staph) Infection
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 146
- Enrollment target
NCT00108160 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 146 participants.
The verdict
NCT00108160, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 146 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG) ointment \[Treatment Arm\] is effective in preventing moderate to severe re-infection with Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment \[Placebo Arm\].
Interventions
- DRUG Mupirocin Ointment [Treatment]
- DRUG Polyethylene Glycol Ointment [Placebo]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2005-04 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108160
The ClinicalTrials.gov registry entry for NCT00108160 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mupirocin Ointment [Treatment] is the first listed.
NCT00108160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108160 about?
NCT00108160 is a clinical study titled "Preventing Staphylococcal (Staph) Infection". The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG) ointment \[Treatment Arm\] is effective in preventing moderate to severe re-infection with Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment \[Placebo Arm\].
What is the current status of trial NCT00108160?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 146 participants. The study started on 2005-04. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00108160?
The interventions under investigation include: Mupirocin Ointment [Treatment] (DRUG), Polyethylene Glycol Ointment [Placebo] (DRUG).
Who is sponsoring clinical trial NCT00108160?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.